Aqtual, Inc.
Signe Fransen is a seasoned professional in the field of scientific and medical affairs with a diverse background spanning over two decades. Currently serving as Vice President of Scientific and Medical Affairs at Aqtual, Inc. since February 2024, Signe previously held the position of Vice President, Clinical and Medical Affairs at Strata Oncology from May 2023 to December 2023. Earlier, Signe operated as a Scientific & Medical Affairs Consultant and as Vice President of Scientific & Medical Affairs at Salish Bioscience Inc. Signe's extensive experience also includes significant roles at Freenome, Bristol-Myers Squibb, and Monogram Biosciences. Signe holds a Master of Science in Microbiology and Immunology from McMaster University, earned between 1997 and 1999.
This person is not in any teams
Aqtual, Inc.
Aqtual, Inc. is a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology. Our mission is to revolutionize the treatment and management of these conditions by bridging the translational gap between groundbreaking research and practical healthcare solutions.